InvestorsHub Logo
Followers 285
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: Bluesummers post# 218434

Thursday, 07/28/2016 6:03:27 AM

Thursday, July 28, 2016 6:03:27 AM

Post# of 399493

ELTP and the FDA have to get this sorted but it ultimately will happen because they have the best product to put to market (i.e. among current know competitors).

Additionally, the market is in desperate need of such a pharmaceutical. The FDA is only doing this as precaution (IMO) because it will fill a major sector of the market regarding painkillers (i.e. they are taking every precaution).


The FDA understands it needs to tackle the prescription opioid epidemic. It told Elite the fatty meal "issue" was a label issue previously and now it has said it is a "safety" issue. Typical big government BS it states one thing and then behind closed doors it does another.

Eugene Pfeifer will come away with a path forward for Elite. Some say Elite wasn't blind sided by this.....as if hiring Eugene Pfeifer post NDA submission doesn't say otherwise.

And one has to keep in mind the FDA previously telling Elite they didn't have to perform a phase 3 trial and then "changing" their mind thereafter.

Nasrat came from the big leagues. He is the consumate professional. He'll figure out what is necessary to move SequestOx to market IMO.

Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News